INFLECTRA 100 mg/10mL
infliximab-dyyb · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
INFLECTRA is a injection, powder, lyophilized, for solution containing infliximab-dyyb at 100 mg/10mL, taken intravenous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- INFLECTRA
- Generic Name
- infliximab-dyyb
- NDC Code (Product)
0069-0809- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 100 mg/10mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125544
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 11/21/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is INFLECTRA used for?
INFLECTRA contains infliximab-dyyb. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is INFLECTRA a controlled substance?
INFLECTRA is not classified as a controlled substance by the DEA.
What is the generic name for INFLECTRA?
The generic name for INFLECTRA is infliximab-dyyb. There are 2 other brand versions of infliximab-dyyb.
What is the NDC code for INFLECTRA 100 mg/10mL?
The NDC (National Drug Code) for INFLECTRA 100 mg/10mL is 0069-0809, listed by Pfizer Laboratories Div Pfizer Inc.